Latest Recruitment News

Iluka Resources has exceeded its 2024 production guidance with robust zircon and synthetic rutile output, while advancing key projects and implementing cost-saving measures ahead of 2025.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Polymetals Resources is advancing steadily towards restarting production at its high-grade Endeavor silver-zinc mine, fully funded and on track for first output in the first half of 2025.